Provided by Tiger Trade Technology Pte. Ltd.

Immunoprecise Antibodies Ltd

2.07
0.0000
Volume:- -
Turnover:4.36M
Market Cap:95.54M
PE:-3.16
High:2.07
Open:2.07
Low:2.07
Close:2.07
52wk High:3.25
52wk Low:0.2700
Shares:46.15M
Float Shares:41.95M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6554
EPS(LYR):-0.6554
ROE:-101.96%
ROA:-14.81%
PB:5.53
PE(LYR):-3.16

Loading ...

BRIEF-Immunoprecise Rebrands As Mindwalk, Announces Nasdaq Ticker Change To “Hyft”

Reuters
·
Sep 03, 2025

Immunoprecise Rebrands as Mindwalk, Announces Nasdaq Ticker Change to “Hyft”

THOMSON REUTERS
·
Sep 03, 2025

ImmunoPrecise Antibodies Ltd. to Participate in H.C. Wainwright's 27th Annual Global Investment Conference

Reuters
·
Sep 02, 2025

Flyers’ Garnet Hathaway Launches Engine 19 IPA with Dogfish Head Craft Brewery to Support Local First Responders

GlobeNewswire
·
Aug 28, 2025

ImmunoPrecise Antibodies Ltd. Advances Universal Dengue Vaccine Initiative to Preclinical Manufacturing Stage

Reuters
·
Aug 27, 2025

Immunoprecise Antibodies Ltd. Divests Netherlands Facilities To AVS Bio

Reuters
·
Aug 06, 2025

AVS Bio Acquires ImmunoPrecise Antibodies Europe, Expanding Antibody Discovery and Protein Production Capabilities

Reuters
·
Aug 06, 2025

Immunoprecise Antibodies Ltd - Proceeds to Support Investment in Scientific Platforms

THOMSON REUTERS
·
Aug 06, 2025

Immunoprecise Antibodies Ltd. Divests Netherlands Facilities to Avs Bio to Accelerate Bio-Native AI Innovation

THOMSON REUTERS
·
Aug 06, 2025

ImmunoPrecise Antibodies Ltd. Announces Date for Upcoming Annual General Meeting

Reuters
·
Aug 06, 2025

ImmunoPrecise Antibodies Ltd. Releases Transcript of Q4 2025 Earnings Call Event

Reuters
·
Jul 31, 2025

ImmunoPrecise Antibodies Q4 2025 EPS $(0.04) Misses $(0.02) Estimate, Sales $5.050M Miss $5.980M Estimate

Benzinga
·
Jul 29, 2025

Biotech firm ImmunoPrecise's FY25 revenue misses estimates

Reuters
·
Jul 29, 2025

Immunoprecise Antibodies Ltd - Qtrly Shr Loss $0.05; Qtrly Revenue About $7 Mln

THOMSON REUTERS
·
Jul 29, 2025

Immunoprecise Antibodies FY Revenue CAD 24.5 Million

THOMSON REUTERS
·
Jul 29, 2025

Immunoprecise Antibodies (Ipa) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted Ebitda

THOMSON REUTERS
·
Jul 29, 2025

ImmunoPrecise Antibodies Ltd. Achieves Record Fiscal 2025 Revenue of $24.5M; Reports Improved Fourth Quarter Adjusted EBITDA of ($0.3)M

Reuters
·
Jul 29, 2025